We are live on ! Find out more
SRC

Shufro Rose & Co Portfolio holdings

AUM $1.47B
1-Year Est. Return 19.38%
This Fund
S&P 500
This Quarter Est. Return
-20.53%
1 Year Est. Return
+19.38%
3 Year Est. Return
+47.49%
5 Year Est. Return
+55.37%
10 Year Est. Return
+200.77%
AUM
$839M
AUM Growth
-$270M
Cap. Flow
-$14.8M
Cap. Flow %
-1.77%
Top 10 Hldgs %
36.87%
Holding
331
New
17
Increased
51
Reduced
134
Closed
38

Top Buys

Rank Stock Value
1
CRM icon
Salesforce
CRM
+$8.37M
2
TMO icon
Thermo Fisher Scientific
TMO
+$6.02M
3
AMZN icon
Amazon
AMZN
+$3.56M
4
MSFT icon
Microsoft
MSFT
+$3.42M
5
EL icon
Estee Lauder
EL
+$2.8M

Top Sells

Rank Stock Value
1
INTC icon
Intel
INTC
+$11.2M
2
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$2.55M
3
AMGN icon
Amgen
AMGN
+$1.98M
4
GM icon
General Motors
GM
+$1.96M
5
HD icon
Home Depot
HD
+$1.28M

Sector Composition

Rank Sector Weight
1 Technology 23.11%
2 Healthcare 14.78%
3 Financials 13.66%
4 Consumer Discretionary 11.04%
5 Industrials 7.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RSP icon
1
Invesco S&P 500 Equal Weight ETF
RSP
$96.1B
$55M 6.55%
654,101
-6,392
-1% -$679K
BSCM
2
DELISTED
Invesco BulletShares 2022 Corporate Bond ETF
BSCM
$43M 5.12%
2,028,004
+13,722
+0.7% +$292K
INTC icon
3
Intel
INTC
$466B
$37.6M 4.49%
694,935
-188,556
-21% -$11.2M
GLW icon
4
Corning
GLW
$126B
$32M 3.81%
1,556,710
-38,095
-2% -$994K
BSCN
5
DELISTED
Invesco BulletShares 2023 Corporate Bond ETF
BSCN
$28M 3.34%
1,353,154
+51,834
+4% +$1.09M
BMY icon
6
Bristol-Myers Squibb
BMY
$127B
$25.2M 3%
451,438
-8,150
-2% -$498K
AVY icon
7
Avery Dennison
AVY
$12.3B
$23M 2.74%
225,500
-4,629
-2% -$567K
BRK.B icon
8
Berkshire Hathaway Class B
BRK.B
$1.07T
$22.3M 2.66%
121,802
-4,562
-4% -$970K
TMO icon
9
Thermo Fisher Scientific
TMO
$211B
$21.9M 2.61%
77,302
+19,098
+33% +$6.02M
MSFT icon
10
Microsoft
MSFT
$2.84T
$21.3M 2.54%
134,802
+20,775
+18% +$3.42M
TXN icon
11
Texas Instruments
TXN
$255B
$20.4M 2.43%
203,670
-6,423
-3% -$771K
CSCO icon
12
Cisco
CSCO
$450B
$19.3M 2.3%
489,831
-19,534
-4% -$857K
AGN
13
DELISTED
Allergan plc
AGN
$18.7M 2.23%
105,774
-1,629
-2% -$307K
UNH icon
14
UnitedHealth
UNH
$382B
$17.4M 2.08%
69,963
-3,867
-5% -$1.06M
AMGN icon
15
Amgen
AMGN
$203B
$16.4M 1.96%
81,054
-9,086
-10% -$1.98M
SON icon
16
Sonoco
SON
$5.76B
$16.3M 1.95%
351,959
-7,554
-2% -$403K
AAPL icon
17
Apple
AAPL
$4.89T
$16M 1.9%
251,096
-12,768
-5% -$939K
QCOM icon
18
Qualcomm
QCOM
$176B
$15.9M 1.9%
235,609
-3,504
-1% -$287K
JPM icon
19
JPMorgan Chase
JPM
$939B
$14.8M 1.76%
164,155
-4,276
-3% -$520K
Y
20
DELISTED
Alleghany Corp
Y
$14.8M 1.76%
26,720
-1,241
-4% -$893K
JCI icon
21
Johnson Controls International
JCI
$87.5B
$12.5M 1.49%
461,961
-12,209
-3% -$455K
BWA icon
22
BorgWarner
BWA
$13.2B
$11M 1.32%
514,444
-11,075
-2% -$320K
SBUX icon
23
Starbucks
SBUX
$118B
$10.1M 1.21%
154,292
-2,394
-2% -$194K
LEN icon
24
Lennar Class A
LEN
$20.4B
$10.1M 1.21%
273,616
-18,230
-6% -$1.03M
MET icon
25
MetLife
MET
$61B
$9.23M 1.1%
301,866
-6,848
-2% -$304K

Similar funds

Shufro Rose & Co's Q1 2020 Portfolio in Review

As of Q1 2020, Shufro Rose & Co held 331 positions worth $839M, down 24% from $1.11B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Shufro Rose & Co's Q1 2020 filing shows 17 new, 51 increased, 134 reduced and 38 closed positions. Its largest new stake was Salesforce: 48,843 shares worth $7.03M. The largest sale was Intel, an estimated $11.2M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • Shufro Rose & Co's largest Q1 2020 buy was Salesforce: 48,843 shares worth $7.03M.
  • Shufro Rose & Co added most to Thermo Fisher Scientific in Q1 2020, an estimated $6.02M increase.
  • Shufro Rose & Co's biggest Q1 2020 reduction was Intel, cutting an estimated $11.2M.
  • Shufro Rose & Co fully exited Ventas in Q1 2020, selling an estimated $1.05M.
  • Shufro Rose & Co's ten largest holdings make up 37% of its $839M portfolio in Q1 2020.
  • Shufro Rose & Co opened 17 new positions and closed 38 in Q1 2020.
  • Shufro Rose & Co's portfolio value fell 24% quarter-over-quarter to $839M.

Based on Shufro Rose & Co's 13F filing for Q1 2020, filed 22 Apr 2020.